Evidence map›Paper›PMID 40021955›Full record

ArticleBMC nephrology2025

Design and psychometric validation of a social capital questionnaire for adults with end-stage chronic kidney disease undergoing dialysis or hemodialysis.

Alicia Alanis-Ocádiz, Svetlana V Doubova, José Manuel Arreola-Guerra, Adriana Monroy, Jannett Padilla-López, Carolina Quiñones-Villalobos, Carlos Alberto Prado-Aguilar

Abstract readValidation Study
In one paragraph

Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alicia Alanis-OcádizPrograma de Doctorado en Ciencias Médicas, Odontológicas y de la Salud, Universidad Nacional Autónoma de México, Av. Universidad 3004, Copilco Universidad, Coyoacán, Ciudad de México, 04510, México.
Svetlana V DoubovaUnidad de Investigación en Epidemiologia y Servicios de Salud del Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Av. Cuauhtémoc 330, Col. Doctores, Cuauhtémoc, Ciudad de México, 06720, México. svetlana.doubova@gmail.com.
José Manuel Arreola-GuerraDepartamento de Nefrología Centenario Hospital Miguel Hidalgo, Av. Manuel Gómez Morín s/n Col. Alameda, Aguascalientes, 20259, México.
Adriana MonroyCoordinación de Investigación en Oncología. Hospital General de México, "Dr. Eduardo Liceaga". Dr. Balmis 148, Col. Doctores, Cuauhtémoc, Ciudad de México, 06720, México.
Jannett Padilla-LópezPrograma de Doctorado en Ciencias Médicas, Odontológicas y de la Salud, Universidad Nacional Autónoma de México, Av. Universidad 3004, Copilco Universidad, Coyoacán, Ciudad de México, 04510, México.
Carolina Quiñones-VillalobosPrograma de Doctorado en Ciencias Médicas, Odontológicas y de la Salud, Universidad Nacional Autónoma de México, Av. Universidad 3004, Copilco Universidad, Coyoacán, Ciudad de México, 04510, México.
Carlos Alberto Prado-AguilarCoordinación Médica de Investigación del Instituto Mexicano del Seguro Social OOAD Aguascalientes, Av. José María Chávez 1202, Lindavista, Aguascalientes, 20270, México.

Funding

Instituto Mexicano del Seguro Social R-2022-785-053
6 · The paper itself

Abstract

backgroundThe effects of end-stage kidney disease (ESKD) can spill over into a patient's social life. Social capital (SC) is a determinant of health that can enhance patients' health through support and resources. However, no questionnaire is currently available to measure SC in ESKD patients. This study aimed to design and validate a questionnaire to measure SC in ESKD adults undergoing dialysis or hemodialysis.

methodsA mixed methods approach was used to generate the questionnaire and determine its content validity with a panel of nine experts and content validity index, face validity through cognitive interviews with patients, construct validity (exploratory and confirmatory factor analysis), criterion validity, reliability and the effect of known groups differences.

resultsContent validity was confirmed by an expert panel, achieving a content validity index value > 0.85 for all items. Face validity was achieved through cognitive interviews with 20 patients over 18 years of age in a terminal stage of CKD, ensuring that the target population understood the questions. An exploratory factor analysis used the sample of 610 patients and tested the structure of the seven dimensions of the structural domain (participation in organizations, links to institutions, social network sizes, collective activities, diversity, bridging, and bonding) and explained 95.7% of the total variance with a reliability of 0.89, and criterion validity > 0.32 (p < 0.05) for the correlations between the indices of each dimension and the domain index. The structure of the cognitive domain was tested for six dimensions (norms of reciprocity, social harmony, feeling of belonging, perceived fairness, social support, and social trust) with a total variance of 80.7%, reliability of 0.94 and criterion validity for correlations > 0.68 (p < 0.05). The confirmatory factor analysis with 352 patients proved the factorial structure adequate for both questionnaire domains and all dimensions, with CFI and TLI values > 0.9, an RMSEA ≤ 0.06, and SRMR ≤ 0.05.

conclusionsWe conclude that the questionnaire designed to measure social capital is valid and reliable for ESKD patients in Mexico.

Indexed as

Kidney Failure, ChronicRenal DialysisSocial CapitalAdultAgedFemaleHumansMaleMiddle AgedPsychometricsReproducibility of ResultsSocial SupportSurveys and QuestionnairesEnd stage kidney diseaseQuestionnaireReliabilitySocial capitalValidity

Identifiers

PMID40021955
PMCPMC11871631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.